Suppr超能文献

禁食尿液渗透压、慢性肾脏病进展和死亡率:一项前瞻性观察研究。

Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.

机构信息

Sorbonne Université, Inserm UMR_S 1155, Paris, France; Unit of Renal Physiology, AP-HP Hôpital Tenon, Paris, France.

CESP, Inserm U1018, Univ Paris-Saclay, Univ Paris-Sud, UVSQ, Villejuif, France; FCRIN INI-CRCT, France.

出版信息

Am J Kidney Dis. 2019 May;73(5):596-604. doi: 10.1053/j.ajkd.2018.12.024. Epub 2019 Feb 15.

Abstract

RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) characterized by decreased glomerular filtration rate (GFR) is often accompanied by various degrees of impaired tubular function in the cortex and medulla. Assessment of tubular function may therefore be useful in establishing the severity of kidney disease and identifying those at greater risk for CKD progression. We explored reductions in urinary concentrating ability, a well-known feature of CKD, as a risk factor for GFR decline and end-stage renal disease (ESRD).

STUDY DESIGN

Prospective longitudinal cohort study.

SETTING & PARTICIPANTS: 2,084 adult patients with CKD stages 1 to 4 from the French NephroTest Cohort Study.

PREDICTOR

Fasting urinary osmolality measured using delta cryoscopy.

OUTCOMES

ESRD, mortality before ESRD, and measured GFR (mGFR) assessed using Cr-EDTA renal clearance.

ANALYTICAL APPROACH

Cause-specific hazards models were fit to estimate crude and adjusted associations of urinary osmolality with ESRD and death before ESRD. Linear mixed models with random intercepts were fit to evaluate the association of urinary osmolality with slope of decline in mGFR.

RESULTS

At baseline, mean age was 58.7±15.2 (SD) years with a median mGFR of 40.2 (IQR, 29.1-54.5) mL/min/1.73m and a median fasting urinary osmolality of 502.7±151.7mOsm/kg HO. Baseline fasting urinary osmolality was strongly associated with mGFR (R=0.54; P < 0.001). 380 ESRD events and 225 deaths before ESRD occurred during a median follow-up of 5.9 (IQR, 3.8-8.2) years. Patients with lower baseline fasting urinary osmolality had higher adjusted risk for ESRD but not for mortality (HRs of 1.97 [95% CI, 1.26-3.08] and 0.99 [95% CI, 0.68-1.44], respectively, for the lowest vs highest tertile). Based on a mixed linear model adjusted for baseline mGFR and clinical characteristics, patients in the lowest tertile of baseline urinary osmolality had a steeper decline in kidney function (-4.9% ± 0.9% per year; P < 0.001) compared with patients in the highest tertile.

LIMITATIONS

Fasting was self-reported.

CONCLUSIONS

Fasting urinary osmolality may be a useful tool, in addition to GFR and albuminuria, for assessing nonglomerular damage in patients with CKD who are at higher risk for CKD progression.

摘要

背景与目的

慢性肾脏病(CKD)的特征是肾小球滤过率(GFR)下降,常伴有皮质和髓质肾小管功能的不同程度损害。因此,评估肾小管功能可能有助于确定肾脏疾病的严重程度,并识别那些更有可能进展为 CKD 的患者。我们探讨了尿浓缩能力的降低,这是 CKD 的一个众所周知的特征,作为 GFR 下降和终末期肾病(ESRD)的危险因素。

研究设计

前瞻性纵向队列研究。

研究地点和参与者

来自法国 NephroTest 队列研究的 2084 名 CKD 1 至 4 期的成年患者。

预测因子

使用差示冰点测定法测量空腹尿渗透压。

结局

ESRD、ESRD 前死亡和使用 Cr-EDTA 肾清除率评估的估计肾小球滤过率(mGFR)。

分析方法

采用因果风险模型估计尿渗透压与 ESRD 和 ESRD 前死亡的粗关联和调整关联。采用具有随机截距的线性混合模型评估尿渗透压与 mGFR 下降斜率的关联。

结果

基线时,平均年龄为 58.7±15.2(SD)岁,中位 mGFR 为 40.2(IQR,29.1-54.5)mL/min/1.73m,中位空腹尿渗透压为 502.7±151.7mOsm/kgHO。基线空腹尿渗透压与 mGFR 呈强相关(R=0.54;P<0.001)。在中位随访 5.9(IQR,3.8-8.2)年期间,发生了 380 例 ESRD 事件和 225 例 ESRD 前死亡。基线空腹尿渗透压较低的患者调整后的 ESRD 风险较高,但死亡率无差异(最低与最高三分位组的风险比分别为 1.97(95%CI,1.26-3.08)和 0.99(95%CI,0.68-1.44))。基于调整基线 mGFR 和临床特征的混合线性模型,基线尿渗透压最低三分位的患者肾功能下降更陡峭(每年-4.9%±0.9%;P<0.001)与最高三分位组相比。

局限性

空腹状态为自我报告。

结论

除了 GFR 和白蛋白尿外,空腹尿渗透压可能是一种有用的工具,用于评估肾小球滤过率下降和蛋白尿患者的非肾小球损伤,这些患者更有可能进展为 CKD。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验